Organisatie
Immunomodulatie in Chronische Ontstekingsziekten
Research Group
De onderzoeksgroep Immunomodulatie bij chronische onstekingsziekten
Projecten
1 - 3 of 3
- Doelgericht onderzoek naar de 'X factor' van de long tumor micro- omgeving.Vanaf1 jan 2018 → 31 dec 2018Financiering: FWO Krediet aan Navorser
- Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)Vanaf1 nov 2017 → HedenFinanciering: Univ. - Projectmatig onderzoek
- European HIV Vaccine Alliance (EHVA): een EU-platform voor de ontdekking en evaluatie van nieuwe profylactische en therapeutische vaccinkandidatenVanaf1 jan 2016 → 30 jun 2023Financiering: H2020 - Gezondheid, demografische verandering en welzijn
Publicaties
1 - 10 van 29
- Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)(2017)
Auteurs: A.C. Guardo, Patrick Tjok Joe, L Miralles, M.E. Bargallo, B Mothe, Ahmet Krasniqi, Carlo Heirman, F Garcia, Kris Thielemans, C Brander, et al.
Pagina's: 321-332 - Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells(2016)
Auteurs: Sandra Van Lint, Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Du Four, Kevin Van der Jeught, Lukasz Bialkowski, et al.
Pagina's: 146-156 - Thymus-derived regulatory T cells restrain pro-inflammatory Th1 responses by downregulating CD70 on dendritic cells(2015)
Auteurs: Maxime Dhainaut, Caroline Coquerelle, Sophie Uzureau, Julie Denoeud, Valérie Acolty, Guillaume Oldenhove, Adrien Galuppo, Tim Sparwasser, Kris Thielemans, Etienne Pays, et al.
Pagina's: 1336-1348 - Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules(2016)
Auteurs: Wenbin Ma, Yi Zhang, Nathalie Vigneron, Vincent Stroobant, Kris Thielemans, Pierre Van Der Bruggen, Benoît J Van den Eynde
Pagina's: 1711-1720 - iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy(2019)
Auteurs: Wesley de Jong, Joeri L Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric van Gorp, Guido Vanham, Lorna Leal, Beatriz Mothe, et al.
- Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients(2016)
Auteurs: Teofila Seremet, Alexander Koch, Yanina Jansen, Max Schreuer, Sofie Wilgenhof, Veronique Del Marmol, Danielle Lienard, Kris Thielemans, Kelly A Schats, Mark Kockx, et al.
- Long-term disease-free survival following dendritic cell therapy and resection of small bowel melanoma metastases - a case report(2011)
Auteurs: Kim Vanderlinden, Sofie Wilgenhof, Nele Van De Winkel, Caroline Geers, Kris Thielemans, Bart Neyns, Kristel De Vogelaere, Georges Delvaux
Pagina's: 3579-3583 - Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases(2015)
Auteurs: Sofie Wilgenhof, Jurgen Corthals, An Van Nuffel, Daphné Benteyn, Carlo Heirman, Kris Thielemans, Bart Neyns
Pagina's: 381-388 - Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation(2018)
Auteurs: Willem Staels, Yannick Verdonck, Yves Heremans, Gunter Leuckx, Sofie De Groef, Carlo Heirman, Eelco De Koning, Conny Gysemans, Kris Thielemans, Luc Baeyens, et al.
Pagina's: 1804-1810 - Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs(2016)
Auteurs: Stephanie Du Four, Sarah Maenhout, Simone P Niclou, Kris Thielemans, Bart Neyns, Joeri L Aerts
Pagina's: 2514-2531